M&T Bank
GMAB icon

M&T Bank’s Genmab GMAB Stock Holding History

M&T Bank’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,462
Closed -$254K – 1812
2026
Q1 		$254K Buy
9,462
+331
+4% +$9.92K ﹤0.01% 1454
2025
Q4 		$281K Buy
9,131
+1,170
+15% +$36.5K ﹤0.01% 1428
2025
Q3 		$244K Buy
+7,961
New +$194K ﹤0.01% 1302
2024
Q1 		– Sell
-15,432
Closed -$492K – 1637
2023
Q4 		$492K Buy
15,432
+7,213
+88% +$226K ﹤0.01% 1132
2023
Q3 		$290K Buy
8,219
+1,043
+15% +$39.7K ﹤0.01% 1287
2023
Q2 		$272K Buy
7,176
+312
+5% +$12.4K ﹤0.01% 1345
2023
Q1 		$259K Buy
6,864
+1,274
+23% +$49K ﹤0.01% 1363
2022
Q4 		$237K Buy
+5,590
New +$230K ﹤0.01% 1403
2021
Q3 		– Sell
-5,400
Closed -$220K – 1585
2021
Q2 		$220K Buy
+5,400
New +$208K ﹤0.01% 1420
2021
Q1 		– Sell
-6,259
Closed -$254K – 1622
2020
Q4 		$254K Buy
6,259
+308
+5% +$11.5K ﹤0.01% 1400
2020
Q3 		$218K Sell
5,951
-651
-10% -$23.5K ﹤0.01% 1382
2020
Q2 		$224K Sell
6,602
-5,808
-47% -$158K ﹤0.01% 1328
2020
Q1 		$262K Buy
12,410
+1,975
+19% +$44K ﹤0.01% 1197
2019
Q4 		$233K Buy
+10,435
New +$228K ﹤0.01% 1197

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

M&T Bank's GMAB Position: Q2 2026 in Review

M&T Bank sold out of Genmab (GMAB) in Q2 2026, closing a stake of 9,462 shares — an estimated $254K sold.

M&T Bank first reported a position in GMAB in Q4 2019 and held it in 14 quarters. The position peaked at $492K in Q4 2023. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • M&T Bank reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • M&T Bank sold 9,462 Genmab shares in Q2 2026, an estimated $254K.
  • M&T Bank first reported a position in Genmab in Q4 2019 and held it in 14 quarters.
  • M&T Bank's Genmab position peaked at $492K in Q4 2023.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.